PDA Industry and Honor Award Winners
Class of 2024
Honorary Membership*
PDA's most prestigious award, conferring lifetime membership benefits to the recipient. The award is given in recognition of very long service, of a very significant nature, to PDA.
Morten Munk
One common denominator for his approach is to have a holistic and broad perspective on all aspects and steps in the production of biopharmaceuticals.
I find it extremely awarding, to receive such a recognition from colleagues and peers in the industry. PDA is able to foster and support a unique platform for connecting people in the industry, which allows all of us to learn and share knowledge with colleagues from many areas of the industry, including regulators, suppliers and end-users, and that is even some who might be your competitors. However, independent of your association with the industry, PDA offers a community where all people are open to interact and share their passion to make a difference for patients. Receiving an award for such a community can only make you proud and even more committed to working even harder to support all the great PDA initiatives.
Receiving a PDA award is noticed by a lot of people in the industry, not only PDA members. It is recognition of a considerable contribution to the industry and opens doors both internally and externally, increasing your impact on the daily work in your company and also influencing the industry to benefit patients in the whole world. Everyone who contributes to the work of PDA uses a lot of their spare time on different PDA activities. This is not possible without the acceptance and active support from employers as well as our families. Because of this, having your contribution recognized is such a precious award.
I have also received the honor of being elected to the PDA Board of Directors. This is an extremely huge honor and I look forward to offering my humble contribution to PDA and the industry in this new role. My professional goals continue to be supporting the development and production of safe and effective medical products in a sustainable way to benefit as many patients around the world as possible. One of the areas I want to focus on even more in the coming years is to act as a mentor and source of knowledge for young entrepreneurs who have dedicated their lives to making innovative and new treatments for people with medical needs.
I am inspired working to help patients to get safe and efficient medicine, and I feel it is a huge commitment to deserve the trust patients have in us as an industry to do our utmost to ensure that the products we develop will help them get well and not make them more ill. As part of this commitment, I’m also passionate about that we do our best to minimize the environmental impact we have on the planet in the process of making medicine; it makes good sense to prevent the planet from sickness due to pollution caused by making medicine. On a more daily basis, I get inspired by working and interacting with people who have a passion for doing their jobs as well as possible. Since I have a curious and scientific mindset, I always want to learn more and be with people who inspire and teach me.
He believes; collaboration, knowledge sharing, and optimal use of all relevant technologies are the key factors in ensuring the availability of the best product for the patient.
Morten joined Fujifilm in 2020 where holds a role as Director, Global Alliance Management.
In 2001 he was one of the co-founders of CMC Biologics (now AGC Biologics) after he had been working 14 years at Novo Nordisk.
Furthermore, Morten has authored or contributed to several technical articles and guidelines. He is frequently invited to give scientific and technical presentations at international conferences. Additionally, he is active in the biopharmaceutical community as a member of scientific committees for various international conferences as well as a volunteer in international industry organizations, where the most important naturally is PDA, but also ISPE and BPOG.
- Service Appreciation Award
Frederick Carleton Award*
This award is designated for a past Board member whose services on the Board are determined by his/her peers as worthy of high recognition. It is presented as a tribute to lifetime contributor Fred Carleton.
Morten Munk
One common denominator for his approach is to have a holistic and broad perspective on all aspects and steps in the production of biopharmaceuticals.
I find it extremely awarding, to receive such a recognition from colleagues and peers in the industry. PDA is able to foster and support a unique platform for connecting people in the industry, which allows all of us to learn and share knowledge with colleagues from many areas of the industry, including regulators, suppliers and end-users, and that is even some who might be your competitors. However, independent of your association with the industry, PDA offers a community where all people are open to interact and share their passion to make a difference for patients. Receiving an award for such a community can only make you proud and even more committed to working even harder to support all the great PDA initiatives.
Receiving a PDA award is noticed by a lot of people in the industry, not only PDA members. It is recognition of a considerable contribution to the industry and opens doors both internally and externally, increasing your impact on the daily work in your company and also influencing the industry to benefit patients in the whole world. Everyone who contributes to the work of PDA uses a lot of their spare time on different PDA activities. This is not possible without the acceptance and active support from employers as well as our families. Because of this, having your contribution recognized is such a precious award.
I have also received the honor of being elected to the PDA Board of Directors. This is an extremely huge honor and I look forward to offering my humble contribution to PDA and the industry in this new role. My professional goals continue to be supporting the development and production of safe and effective medical products in a sustainable way to benefit as many patients around the world as possible. One of the areas I want to focus on even more in the coming years is to act as a mentor and source of knowledge for young entrepreneurs who have dedicated their lives to making innovative and new treatments for people with medical needs.
I am inspired working to help patients to get safe and efficient medicine, and I feel it is a huge commitment to deserve the trust patients have in us as an industry to do our utmost to ensure that the products we develop will help them get well and not make them more ill. As part of this commitment, I’m also passionate about that we do our best to minimize the environmental impact we have on the planet in the process of making medicine; it makes good sense to prevent the planet from sickness due to pollution caused by making medicine. On a more daily basis, I get inspired by working and interacting with people who have a passion for doing their jobs as well as possible. Since I have a curious and scientific mindset, I always want to learn more and be with people who inspire and teach me.
He believes; collaboration, knowledge sharing, and optimal use of all relevant technologies are the key factors in ensuring the availability of the best product for the patient.
Morten joined Fujifilm in 2020 where holds a role as Director, Global Alliance Management.
In 2001 he was one of the co-founders of CMC Biologics (now AGC Biologics) after he had been working 14 years at Novo Nordisk.
Furthermore, Morten has authored or contributed to several technical articles and guidelines. He is frequently invited to give scientific and technical presentations at international conferences. Additionally, he is active in the biopharmaceutical community as a member of scientific committees for various international conferences as well as a volunteer in international industry organizations, where the most important naturally is PDA, but also ISPE and BPOG.
- Service Appreciation Award
Your rating for this document has already been submitted
Gordon Personeus Award*
This Award is intended to honor a PDA member for his or her long-term activities and/or volunteer contributions that are of noteworthy or special importance and have positively impacted PDA in several areas over time. It is presented in memory of the late Gordon Personeus, past PDA President and long-time volunteer.
Morten Munk
One common denominator for his approach is to have a holistic and broad perspective on all aspects and steps in the production of biopharmaceuticals.
I find it extremely awarding, to receive such a recognition from colleagues and peers in the industry. PDA is able to foster and support a unique platform for connecting people in the industry, which allows all of us to learn and share knowledge with colleagues from many areas of the industry, including regulators, suppliers and end-users, and that is even some who might be your competitors. However, independent of your association with the industry, PDA offers a community where all people are open to interact and share their passion to make a difference for patients. Receiving an award for such a community can only make you proud and even more committed to working even harder to support all the great PDA initiatives.
Receiving a PDA award is noticed by a lot of people in the industry, not only PDA members. It is recognition of a considerable contribution to the industry and opens doors both internally and externally, increasing your impact on the daily work in your company and also influencing the industry to benefit patients in the whole world. Everyone who contributes to the work of PDA uses a lot of their spare time on different PDA activities. This is not possible without the acceptance and active support from employers as well as our families. Because of this, having your contribution recognized is such a precious award.
I have also received the honor of being elected to the PDA Board of Directors. This is an extremely huge honor and I look forward to offering my humble contribution to PDA and the industry in this new role. My professional goals continue to be supporting the development and production of safe and effective medical products in a sustainable way to benefit as many patients around the world as possible. One of the areas I want to focus on even more in the coming years is to act as a mentor and source of knowledge for young entrepreneurs who have dedicated their lives to making innovative and new treatments for people with medical needs.
I am inspired working to help patients to get safe and efficient medicine, and I feel it is a huge commitment to deserve the trust patients have in us as an industry to do our utmost to ensure that the products we develop will help them get well and not make them more ill. As part of this commitment, I’m also passionate about that we do our best to minimize the environmental impact we have on the planet in the process of making medicine; it makes good sense to prevent the planet from sickness due to pollution caused by making medicine. On a more daily basis, I get inspired by working and interacting with people who have a passion for doing their jobs as well as possible. Since I have a curious and scientific mindset, I always want to learn more and be with people who inspire and teach me.
He believes; collaboration, knowledge sharing, and optimal use of all relevant technologies are the key factors in ensuring the availability of the best product for the patient.
Morten joined Fujifilm in 2020 where holds a role as Director, Global Alliance Management.
In 2001 he was one of the co-founders of CMC Biologics (now AGC Biologics) after he had been working 14 years at Novo Nordisk.
Furthermore, Morten has authored or contributed to several technical articles and guidelines. He is frequently invited to give scientific and technical presentations at international conferences. Additionally, he is active in the biopharmaceutical community as a member of scientific committees for various international conferences as well as a volunteer in international industry organizations, where the most important naturally is PDA, but also ISPE and BPOG.
- Service Appreciation Award
Your rating for this document has already been submitted
Michael Korczynski Award*
This Award is presented to recognize contributions to PDA’s international activities. It is named for Michael S. Korczynski in recognition of the contributions he made toward the development of PDA’s international activities.
Morten Munk
One common denominator for his approach is to have a holistic and broad perspective on all aspects and steps in the production of biopharmaceuticals.
I find it extremely awarding, to receive such a recognition from colleagues and peers in the industry. PDA is able to foster and support a unique platform for connecting people in the industry, which allows all of us to learn and share knowledge with colleagues from many areas of the industry, including regulators, suppliers and end-users, and that is even some who might be your competitors. However, independent of your association with the industry, PDA offers a community where all people are open to interact and share their passion to make a difference for patients. Receiving an award for such a community can only make you proud and even more committed to working even harder to support all the great PDA initiatives.
Receiving a PDA award is noticed by a lot of people in the industry, not only PDA members. It is recognition of a considerable contribution to the industry and opens doors both internally and externally, increasing your impact on the daily work in your company and also influencing the industry to benefit patients in the whole world. Everyone who contributes to the work of PDA uses a lot of their spare time on different PDA activities. This is not possible without the acceptance and active support from employers as well as our families. Because of this, having your contribution recognized is such a precious award.
I have also received the honor of being elected to the PDA Board of Directors. This is an extremely huge honor and I look forward to offering my humble contribution to PDA and the industry in this new role. My professional goals continue to be supporting the development and production of safe and effective medical products in a sustainable way to benefit as many patients around the world as possible. One of the areas I want to focus on even more in the coming years is to act as a mentor and source of knowledge for young entrepreneurs who have dedicated their lives to making innovative and new treatments for people with medical needs.
I am inspired working to help patients to get safe and efficient medicine, and I feel it is a huge commitment to deserve the trust patients have in us as an industry to do our utmost to ensure that the products we develop will help them get well and not make them more ill. As part of this commitment, I’m also passionate about that we do our best to minimize the environmental impact we have on the planet in the process of making medicine; it makes good sense to prevent the planet from sickness due to pollution caused by making medicine. On a more daily basis, I get inspired by working and interacting with people who have a passion for doing their jobs as well as possible. Since I have a curious and scientific mindset, I always want to learn more and be with people who inspire and teach me.
He believes; collaboration, knowledge sharing, and optimal use of all relevant technologies are the key factors in ensuring the availability of the best product for the patient.
Morten joined Fujifilm in 2020 where holds a role as Director, Global Alliance Management.
In 2001 he was one of the co-founders of CMC Biologics (now AGC Biologics) after he had been working 14 years at Novo Nordisk.
Furthermore, Morten has authored or contributed to several technical articles and guidelines. He is frequently invited to give scientific and technical presentations at international conferences. Additionally, he is active in the biopharmaceutical community as a member of scientific committees for various international conferences as well as a volunteer in international industry organizations, where the most important naturally is PDA, but also ISPE and BPOG.
- Service Appreciation Award
Your rating for this document has already been submitted
James P. Agalloco Award
This award is presented annually to the PDA TRI faculty member who exemplifies outstanding performance in education. The selection is based on student and faculty evaluations. It is named for James P. Agalloco in honor of his work in developing the PDA education program.
Morten Munk
One common denominator for his approach is to have a holistic and broad perspective on all aspects and steps in the production of biopharmaceuticals.
I find it extremely awarding, to receive such a recognition from colleagues and peers in the industry. PDA is able to foster and support a unique platform for connecting people in the industry, which allows all of us to learn and share knowledge with colleagues from many areas of the industry, including regulators, suppliers and end-users, and that is even some who might be your competitors. However, independent of your association with the industry, PDA offers a community where all people are open to interact and share their passion to make a difference for patients. Receiving an award for such a community can only make you proud and even more committed to working even harder to support all the great PDA initiatives.
Receiving a PDA award is noticed by a lot of people in the industry, not only PDA members. It is recognition of a considerable contribution to the industry and opens doors both internally and externally, increasing your impact on the daily work in your company and also influencing the industry to benefit patients in the whole world. Everyone who contributes to the work of PDA uses a lot of their spare time on different PDA activities. This is not possible without the acceptance and active support from employers as well as our families. Because of this, having your contribution recognized is such a precious award.
I have also received the honor of being elected to the PDA Board of Directors. This is an extremely huge honor and I look forward to offering my humble contribution to PDA and the industry in this new role. My professional goals continue to be supporting the development and production of safe and effective medical products in a sustainable way to benefit as many patients around the world as possible. One of the areas I want to focus on even more in the coming years is to act as a mentor and source of knowledge for young entrepreneurs who have dedicated their lives to making innovative and new treatments for people with medical needs.
I am inspired working to help patients to get safe and efficient medicine, and I feel it is a huge commitment to deserve the trust patients have in us as an industry to do our utmost to ensure that the products we develop will help them get well and not make them more ill. As part of this commitment, I’m also passionate about that we do our best to minimize the environmental impact we have on the planet in the process of making medicine; it makes good sense to prevent the planet from sickness due to pollution caused by making medicine. On a more daily basis, I get inspired by working and interacting with people who have a passion for doing their jobs as well as possible. Since I have a curious and scientific mindset, I always want to learn more and be with people who inspire and teach me.
He believes; collaboration, knowledge sharing, and optimal use of all relevant technologies are the key factors in ensuring the availability of the best product for the patient.
Morten joined Fujifilm in 2020 where holds a role as Director, Global Alliance Management.
In 2001 he was one of the co-founders of CMC Biologics (now AGC Biologics) after he had been working 14 years at Novo Nordisk.
Furthermore, Morten has authored or contributed to several technical articles and guidelines. He is frequently invited to give scientific and technical presentations at international conferences. Additionally, he is active in the biopharmaceutical community as a member of scientific committees for various international conferences as well as a volunteer in international industry organizations, where the most important naturally is PDA, but also ISPE and BPOG.
- Service Appreciation Award
Your rating for this document has already been submitted
Martin VanTrieste Pharmaceutical Science Award*
This award recognizes a volunteer’s outstanding contributions that have advanced the pharmaceutical sciences. It is presented in honor of past Board Member and long-time contributor Martin VanTrieste.
Morten Munk
One common denominator for his approach is to have a holistic and broad perspective on all aspects and steps in the production of biopharmaceuticals.
I find it extremely awarding, to receive such a recognition from colleagues and peers in the industry. PDA is able to foster and support a unique platform for connecting people in the industry, which allows all of us to learn and share knowledge with colleagues from many areas of the industry, including regulators, suppliers and end-users, and that is even some who might be your competitors. However, independent of your association with the industry, PDA offers a community where all people are open to interact and share their passion to make a difference for patients. Receiving an award for such a community can only make you proud and even more committed to working even harder to support all the great PDA initiatives.
Receiving a PDA award is noticed by a lot of people in the industry, not only PDA members. It is recognition of a considerable contribution to the industry and opens doors both internally and externally, increasing your impact on the daily work in your company and also influencing the industry to benefit patients in the whole world. Everyone who contributes to the work of PDA uses a lot of their spare time on different PDA activities. This is not possible without the acceptance and active support from employers as well as our families. Because of this, having your contribution recognized is such a precious award.
I have also received the honor of being elected to the PDA Board of Directors. This is an extremely huge honor and I look forward to offering my humble contribution to PDA and the industry in this new role. My professional goals continue to be supporting the development and production of safe and effective medical products in a sustainable way to benefit as many patients around the world as possible. One of the areas I want to focus on even more in the coming years is to act as a mentor and source of knowledge for young entrepreneurs who have dedicated their lives to making innovative and new treatments for people with medical needs.
I am inspired working to help patients to get safe and efficient medicine, and I feel it is a huge commitment to deserve the trust patients have in us as an industry to do our utmost to ensure that the products we develop will help them get well and not make them more ill. As part of this commitment, I’m also passionate about that we do our best to minimize the environmental impact we have on the planet in the process of making medicine; it makes good sense to prevent the planet from sickness due to pollution caused by making medicine. On a more daily basis, I get inspired by working and interacting with people who have a passion for doing their jobs as well as possible. Since I have a curious and scientific mindset, I always want to learn more and be with people who inspire and teach me.
He believes; collaboration, knowledge sharing, and optimal use of all relevant technologies are the key factors in ensuring the availability of the best product for the patient.
Morten joined Fujifilm in 2020 where holds a role as Director, Global Alliance Management.
In 2001 he was one of the co-founders of CMC Biologics (now AGC Biologics) after he had been working 14 years at Novo Nordisk.
Furthermore, Morten has authored or contributed to several technical articles and guidelines. He is frequently invited to give scientific and technical presentations at international conferences. Additionally, he is active in the biopharmaceutical community as a member of scientific committees for various international conferences as well as a volunteer in international industry organizations, where the most important naturally is PDA, but also ISPE and BPOG.
- Service Appreciation Award
Your rating for this document has already been submitted
Edward Smith PDA Packaging Science Award*
This award was created to recognize outstanding contributions to Pharmaceutical Packaging Science. It is presented in honor of Edward Smith and his long-term contributions to pharmaceutical packaging science.
Morten Munk
One common denominator for his approach is to have a holistic and broad perspective on all aspects and steps in the production of biopharmaceuticals.
I find it extremely awarding, to receive such a recognition from colleagues and peers in the industry. PDA is able to foster and support a unique platform for connecting people in the industry, which allows all of us to learn and share knowledge with colleagues from many areas of the industry, including regulators, suppliers and end-users, and that is even some who might be your competitors. However, independent of your association with the industry, PDA offers a community where all people are open to interact and share their passion to make a difference for patients. Receiving an award for such a community can only make you proud and even more committed to working even harder to support all the great PDA initiatives.
Receiving a PDA award is noticed by a lot of people in the industry, not only PDA members. It is recognition of a considerable contribution to the industry and opens doors both internally and externally, increasing your impact on the daily work in your company and also influencing the industry to benefit patients in the whole world. Everyone who contributes to the work of PDA uses a lot of their spare time on different PDA activities. This is not possible without the acceptance and active support from employers as well as our families. Because of this, having your contribution recognized is such a precious award.
I have also received the honor of being elected to the PDA Board of Directors. This is an extremely huge honor and I look forward to offering my humble contribution to PDA and the industry in this new role. My professional goals continue to be supporting the development and production of safe and effective medical products in a sustainable way to benefit as many patients around the world as possible. One of the areas I want to focus on even more in the coming years is to act as a mentor and source of knowledge for young entrepreneurs who have dedicated their lives to making innovative and new treatments for people with medical needs.
I am inspired working to help patients to get safe and efficient medicine, and I feel it is a huge commitment to deserve the trust patients have in us as an industry to do our utmost to ensure that the products we develop will help them get well and not make them more ill. As part of this commitment, I’m also passionate about that we do our best to minimize the environmental impact we have on the planet in the process of making medicine; it makes good sense to prevent the planet from sickness due to pollution caused by making medicine. On a more daily basis, I get inspired by working and interacting with people who have a passion for doing their jobs as well as possible. Since I have a curious and scientific mindset, I always want to learn more and be with people who inspire and teach me.
He believes; collaboration, knowledge sharing, and optimal use of all relevant technologies are the key factors in ensuring the availability of the best product for the patient.
Morten joined Fujifilm in 2020 where holds a role as Director, Global Alliance Management.
In 2001 he was one of the co-founders of CMC Biologics (now AGC Biologics) after he had been working 14 years at Novo Nordisk.
Furthermore, Morten has authored or contributed to several technical articles and guidelines. He is frequently invited to give scientific and technical presentations at international conferences. Additionally, he is active in the biopharmaceutical community as a member of scientific committees for various international conferences as well as a volunteer in international industry organizations, where the most important naturally is PDA, but also ISPE and BPOG.
- Service Appreciation Award
Your rating for this document has already been submitted
Distinguished Service Award*
Four to six awards are typically given in recognition of volunteers' special acts, contributions, or service over the last year that have contributed to the success and strength of PDA. Examples of the types of activities that are recognized include service as members and leaders of PDA Program Planning committees, Task Forces, Interest Groups, and Chapters.
Morten Munk
One common denominator for his approach is to have a holistic and broad perspective on all aspects and steps in the production of biopharmaceuticals.
I find it extremely awarding, to receive such a recognition from colleagues and peers in the industry. PDA is able to foster and support a unique platform for connecting people in the industry, which allows all of us to learn and share knowledge with colleagues from many areas of the industry, including regulators, suppliers and end-users, and that is even some who might be your competitors. However, independent of your association with the industry, PDA offers a community where all people are open to interact and share their passion to make a difference for patients. Receiving an award for such a community can only make you proud and even more committed to working even harder to support all the great PDA initiatives.
Receiving a PDA award is noticed by a lot of people in the industry, not only PDA members. It is recognition of a considerable contribution to the industry and opens doors both internally and externally, increasing your impact on the daily work in your company and also influencing the industry to benefit patients in the whole world. Everyone who contributes to the work of PDA uses a lot of their spare time on different PDA activities. This is not possible without the acceptance and active support from employers as well as our families. Because of this, having your contribution recognized is such a precious award.
I have also received the honor of being elected to the PDA Board of Directors. This is an extremely huge honor and I look forward to offering my humble contribution to PDA and the industry in this new role. My professional goals continue to be supporting the development and production of safe and effective medical products in a sustainable way to benefit as many patients around the world as possible. One of the areas I want to focus on even more in the coming years is to act as a mentor and source of knowledge for young entrepreneurs who have dedicated their lives to making innovative and new treatments for people with medical needs.
I am inspired working to help patients to get safe and efficient medicine, and I feel it is a huge commitment to deserve the trust patients have in us as an industry to do our utmost to ensure that the products we develop will help them get well and not make them more ill. As part of this commitment, I’m also passionate about that we do our best to minimize the environmental impact we have on the planet in the process of making medicine; it makes good sense to prevent the planet from sickness due to pollution caused by making medicine. On a more daily basis, I get inspired by working and interacting with people who have a passion for doing their jobs as well as possible. Since I have a curious and scientific mindset, I always want to learn more and be with people who inspire and teach me.
He believes; collaboration, knowledge sharing, and optimal use of all relevant technologies are the key factors in ensuring the availability of the best product for the patient.
Morten joined Fujifilm in 2020 where holds a role as Director, Global Alliance Management.
In 2001 he was one of the co-founders of CMC Biologics (now AGC Biologics) after he had been working 14 years at Novo Nordisk.
Furthermore, Morten has authored or contributed to several technical articles and guidelines. He is frequently invited to give scientific and technical presentations at international conferences. Additionally, he is active in the biopharmaceutical community as a member of scientific committees for various international conferences as well as a volunteer in international industry organizations, where the most important naturally is PDA, but also ISPE and BPOG.
- Service Appreciation Award
Your rating for this document has already been submitted
Frederick Simon Award
This award is presented annually for the best paper published in the PDA Journal of Pharmaceutical Science and Technology (JPST). It is named in honor of the late Frederick D. Simon, a previous PDA Director of Scientific Affairs.
Morten Munk
One common denominator for his approach is to have a holistic and broad perspective on all aspects and steps in the production of biopharmaceuticals.
I find it extremely awarding, to receive such a recognition from colleagues and peers in the industry. PDA is able to foster and support a unique platform for connecting people in the industry, which allows all of us to learn and share knowledge with colleagues from many areas of the industry, including regulators, suppliers and end-users, and that is even some who might be your competitors. However, independent of your association with the industry, PDA offers a community where all people are open to interact and share their passion to make a difference for patients. Receiving an award for such a community can only make you proud and even more committed to working even harder to support all the great PDA initiatives.
Receiving a PDA award is noticed by a lot of people in the industry, not only PDA members. It is recognition of a considerable contribution to the industry and opens doors both internally and externally, increasing your impact on the daily work in your company and also influencing the industry to benefit patients in the whole world. Everyone who contributes to the work of PDA uses a lot of their spare time on different PDA activities. This is not possible without the acceptance and active support from employers as well as our families. Because of this, having your contribution recognized is such a precious award.
I have also received the honor of being elected to the PDA Board of Directors. This is an extremely huge honor and I look forward to offering my humble contribution to PDA and the industry in this new role. My professional goals continue to be supporting the development and production of safe and effective medical products in a sustainable way to benefit as many patients around the world as possible. One of the areas I want to focus on even more in the coming years is to act as a mentor and source of knowledge for young entrepreneurs who have dedicated their lives to making innovative and new treatments for people with medical needs.
I am inspired working to help patients to get safe and efficient medicine, and I feel it is a huge commitment to deserve the trust patients have in us as an industry to do our utmost to ensure that the products we develop will help them get well and not make them more ill. As part of this commitment, I’m also passionate about that we do our best to minimize the environmental impact we have on the planet in the process of making medicine; it makes good sense to prevent the planet from sickness due to pollution caused by making medicine. On a more daily basis, I get inspired by working and interacting with people who have a passion for doing their jobs as well as possible. Since I have a curious and scientific mindset, I always want to learn more and be with people who inspire and teach me.
He believes; collaboration, knowledge sharing, and optimal use of all relevant technologies are the key factors in ensuring the availability of the best product for the patient.
Morten joined Fujifilm in 2020 where holds a role as Director, Global Alliance Management.
In 2001 he was one of the co-founders of CMC Biologics (now AGC Biologics) after he had been working 14 years at Novo Nordisk.
Furthermore, Morten has authored or contributed to several technical articles and guidelines. He is frequently invited to give scientific and technical presentations at international conferences. Additionally, he is active in the biopharmaceutical community as a member of scientific committees for various international conferences as well as a volunteer in international industry organizations, where the most important naturally is PDA, but also ISPE and BPOG.
- Service Appreciation Award
Your rating for this document has already been submitted
PDA Letter Article of the Year Award
This reward recognizes an article written by a PDA member during the preceding year that proved popular with PDA’s audience. In addition, the Managing Editor and the Editorial Committee agrees that the article represents quality work deserving of special recognition.
Morten Munk
One common denominator for his approach is to have a holistic and broad perspective on all aspects and steps in the production of biopharmaceuticals.
I find it extremely awarding, to receive such a recognition from colleagues and peers in the industry. PDA is able to foster and support a unique platform for connecting people in the industry, which allows all of us to learn and share knowledge with colleagues from many areas of the industry, including regulators, suppliers and end-users, and that is even some who might be your competitors. However, independent of your association with the industry, PDA offers a community where all people are open to interact and share their passion to make a difference for patients. Receiving an award for such a community can only make you proud and even more committed to working even harder to support all the great PDA initiatives.
Receiving a PDA award is noticed by a lot of people in the industry, not only PDA members. It is recognition of a considerable contribution to the industry and opens doors both internally and externally, increasing your impact on the daily work in your company and also influencing the industry to benefit patients in the whole world. Everyone who contributes to the work of PDA uses a lot of their spare time on different PDA activities. This is not possible without the acceptance and active support from employers as well as our families. Because of this, having your contribution recognized is such a precious award.
I have also received the honor of being elected to the PDA Board of Directors. This is an extremely huge honor and I look forward to offering my humble contribution to PDA and the industry in this new role. My professional goals continue to be supporting the development and production of safe and effective medical products in a sustainable way to benefit as many patients around the world as possible. One of the areas I want to focus on even more in the coming years is to act as a mentor and source of knowledge for young entrepreneurs who have dedicated their lives to making innovative and new treatments for people with medical needs.
I am inspired working to help patients to get safe and efficient medicine, and I feel it is a huge commitment to deserve the trust patients have in us as an industry to do our utmost to ensure that the products we develop will help them get well and not make them more ill. As part of this commitment, I’m also passionate about that we do our best to minimize the environmental impact we have on the planet in the process of making medicine; it makes good sense to prevent the planet from sickness due to pollution caused by making medicine. On a more daily basis, I get inspired by working and interacting with people who have a passion for doing their jobs as well as possible. Since I have a curious and scientific mindset, I always want to learn more and be with people who inspire and teach me.
He believes; collaboration, knowledge sharing, and optimal use of all relevant technologies are the key factors in ensuring the availability of the best product for the patient.
Morten joined Fujifilm in 2020 where holds a role as Director, Global Alliance Management.
In 2001 he was one of the co-founders of CMC Biologics (now AGC Biologics) after he had been working 14 years at Novo Nordisk.
Furthermore, Morten has authored or contributed to several technical articles and guidelines. He is frequently invited to give scientific and technical presentations at international conferences. Additionally, he is active in the biopharmaceutical community as a member of scientific committees for various international conferences as well as a volunteer in international industry organizations, where the most important naturally is PDA, but also ISPE and BPOG.
- Service Appreciation Award
Your rating for this document has already been submitted
PDA Asia Pacific Appreciation Award
This award is given in recognition of special volunteer acts contributing to the success and strength of PDA in the Asia Pacific region.
Morten Munk
One common denominator for his approach is to have a holistic and broad perspective on all aspects and steps in the production of biopharmaceuticals.
I find it extremely awarding, to receive such a recognition from colleagues and peers in the industry. PDA is able to foster and support a unique platform for connecting people in the industry, which allows all of us to learn and share knowledge with colleagues from many areas of the industry, including regulators, suppliers and end-users, and that is even some who might be your competitors. However, independent of your association with the industry, PDA offers a community where all people are open to interact and share their passion to make a difference for patients. Receiving an award for such a community can only make you proud and even more committed to working even harder to support all the great PDA initiatives.
Receiving a PDA award is noticed by a lot of people in the industry, not only PDA members. It is recognition of a considerable contribution to the industry and opens doors both internally and externally, increasing your impact on the daily work in your company and also influencing the industry to benefit patients in the whole world. Everyone who contributes to the work of PDA uses a lot of their spare time on different PDA activities. This is not possible without the acceptance and active support from employers as well as our families. Because of this, having your contribution recognized is such a precious award.
I have also received the honor of being elected to the PDA Board of Directors. This is an extremely huge honor and I look forward to offering my humble contribution to PDA and the industry in this new role. My professional goals continue to be supporting the development and production of safe and effective medical products in a sustainable way to benefit as many patients around the world as possible. One of the areas I want to focus on even more in the coming years is to act as a mentor and source of knowledge for young entrepreneurs who have dedicated their lives to making innovative and new treatments for people with medical needs.
I am inspired working to help patients to get safe and efficient medicine, and I feel it is a huge commitment to deserve the trust patients have in us as an industry to do our utmost to ensure that the products we develop will help them get well and not make them more ill. As part of this commitment, I’m also passionate about that we do our best to minimize the environmental impact we have on the planet in the process of making medicine; it makes good sense to prevent the planet from sickness due to pollution caused by making medicine. On a more daily basis, I get inspired by working and interacting with people who have a passion for doing their jobs as well as possible. Since I have a curious and scientific mindset, I always want to learn more and be with people who inspire and teach me.
He believes; collaboration, knowledge sharing, and optimal use of all relevant technologies are the key factors in ensuring the availability of the best product for the patient.
Morten joined Fujifilm in 2020 where holds a role as Director, Global Alliance Management.
In 2001 he was one of the co-founders of CMC Biologics (now AGC Biologics) after he had been working 14 years at Novo Nordisk.
Furthermore, Morten has authored or contributed to several technical articles and guidelines. He is frequently invited to give scientific and technical presentations at international conferences. Additionally, he is active in the biopharmaceutical community as a member of scientific committees for various international conferences as well as a volunteer in international industry organizations, where the most important naturally is PDA, but also ISPE and BPOG.
- Service Appreciation Award
Your rating for this document has already been submitted
PDA Europe Appreciation Award
This award is given in recognition of special volunteer acts contributing to the success and strength of PDA in Europe.
Morten Munk
One common denominator for his approach is to have a holistic and broad perspective on all aspects and steps in the production of biopharmaceuticals.
I find it extremely awarding, to receive such a recognition from colleagues and peers in the industry. PDA is able to foster and support a unique platform for connecting people in the industry, which allows all of us to learn and share knowledge with colleagues from many areas of the industry, including regulators, suppliers and end-users, and that is even some who might be your competitors. However, independent of your association with the industry, PDA offers a community where all people are open to interact and share their passion to make a difference for patients. Receiving an award for such a community can only make you proud and even more committed to working even harder to support all the great PDA initiatives.
Receiving a PDA award is noticed by a lot of people in the industry, not only PDA members. It is recognition of a considerable contribution to the industry and opens doors both internally and externally, increasing your impact on the daily work in your company and also influencing the industry to benefit patients in the whole world. Everyone who contributes to the work of PDA uses a lot of their spare time on different PDA activities. This is not possible without the acceptance and active support from employers as well as our families. Because of this, having your contribution recognized is such a precious award.
I have also received the honor of being elected to the PDA Board of Directors. This is an extremely huge honor and I look forward to offering my humble contribution to PDA and the industry in this new role. My professional goals continue to be supporting the development and production of safe and effective medical products in a sustainable way to benefit as many patients around the world as possible. One of the areas I want to focus on even more in the coming years is to act as a mentor and source of knowledge for young entrepreneurs who have dedicated their lives to making innovative and new treatments for people with medical needs.
I am inspired working to help patients to get safe and efficient medicine, and I feel it is a huge commitment to deserve the trust patients have in us as an industry to do our utmost to ensure that the products we develop will help them get well and not make them more ill. As part of this commitment, I’m also passionate about that we do our best to minimize the environmental impact we have on the planet in the process of making medicine; it makes good sense to prevent the planet from sickness due to pollution caused by making medicine. On a more daily basis, I get inspired by working and interacting with people who have a passion for doing their jobs as well as possible. Since I have a curious and scientific mindset, I always want to learn more and be with people who inspire and teach me.
He believes; collaboration, knowledge sharing, and optimal use of all relevant technologies are the key factors in ensuring the availability of the best product for the patient.
Morten joined Fujifilm in 2020 where holds a role as Director, Global Alliance Management.
In 2001 he was one of the co-founders of CMC Biologics (now AGC Biologics) after he had been working 14 years at Novo Nordisk.
Furthermore, Morten has authored or contributed to several technical articles and guidelines. He is frequently invited to give scientific and technical presentations at international conferences. Additionally, he is active in the biopharmaceutical community as a member of scientific committees for various international conferences as well as a volunteer in international industry organizations, where the most important naturally is PDA, but also ISPE and BPOG.
- Service Appreciation Award
Your rating for this document has already been submitted
PDA Chapter of the Year Award
This award recognizes the outstanding PDA chapter of the year.
Outstanding Early Career Professional Award
This award is given in recognition of special volunteer acts contributing to the success and strength of PDA by an Early Career Professional
Morten Munk
One common denominator for his approach is to have a holistic and broad perspective on all aspects and steps in the production of biopharmaceuticals.
I find it extremely awarding, to receive such a recognition from colleagues and peers in the industry. PDA is able to foster and support a unique platform for connecting people in the industry, which allows all of us to learn and share knowledge with colleagues from many areas of the industry, including regulators, suppliers and end-users, and that is even some who might be your competitors. However, independent of your association with the industry, PDA offers a community where all people are open to interact and share their passion to make a difference for patients. Receiving an award for such a community can only make you proud and even more committed to working even harder to support all the great PDA initiatives.
Receiving a PDA award is noticed by a lot of people in the industry, not only PDA members. It is recognition of a considerable contribution to the industry and opens doors both internally and externally, increasing your impact on the daily work in your company and also influencing the industry to benefit patients in the whole world. Everyone who contributes to the work of PDA uses a lot of their spare time on different PDA activities. This is not possible without the acceptance and active support from employers as well as our families. Because of this, having your contribution recognized is such a precious award.
I have also received the honor of being elected to the PDA Board of Directors. This is an extremely huge honor and I look forward to offering my humble contribution to PDA and the industry in this new role. My professional goals continue to be supporting the development and production of safe and effective medical products in a sustainable way to benefit as many patients around the world as possible. One of the areas I want to focus on even more in the coming years is to act as a mentor and source of knowledge for young entrepreneurs who have dedicated their lives to making innovative and new treatments for people with medical needs.
I am inspired working to help patients to get safe and efficient medicine, and I feel it is a huge commitment to deserve the trust patients have in us as an industry to do our utmost to ensure that the products we develop will help them get well and not make them more ill. As part of this commitment, I’m also passionate about that we do our best to minimize the environmental impact we have on the planet in the process of making medicine; it makes good sense to prevent the planet from sickness due to pollution caused by making medicine. On a more daily basis, I get inspired by working and interacting with people who have a passion for doing their jobs as well as possible. Since I have a curious and scientific mindset, I always want to learn more and be with people who inspire and teach me.
He believes; collaboration, knowledge sharing, and optimal use of all relevant technologies are the key factors in ensuring the availability of the best product for the patient.
Morten joined Fujifilm in 2020 where holds a role as Director, Global Alliance Management.
In 2001 he was one of the co-founders of CMC Biologics (now AGC Biologics) after he had been working 14 years at Novo Nordisk.
Furthermore, Morten has authored or contributed to several technical articles and guidelines. He is frequently invited to give scientific and technical presentations at international conferences. Additionally, he is active in the biopharmaceutical community as a member of scientific committees for various international conferences as well as a volunteer in international industry organizations, where the most important naturally is PDA, but also ISPE and BPOG.
- Service Appreciation Award
Your rating for this document has already been submitted
Service Appreciation Award
This award is given in recognition of activities performed on behalf of PDA and is awarded at the end of service of specific volunteer leadership positions, including:
- The Board of Directors
- Advisory Board Chairs (intended to be given after stepping down as immediate past chair but can be given earlier when service is cut short)
- Interest Group Leaders
- Chapter Presidents
Morten Munk
One common denominator for his approach is to have a holistic and broad perspective on all aspects and steps in the production of biopharmaceuticals.
I find it extremely awarding, to receive such a recognition from colleagues and peers in the industry. PDA is able to foster and support a unique platform for connecting people in the industry, which allows all of us to learn and share knowledge with colleagues from many areas of the industry, including regulators, suppliers and end-users, and that is even some who might be your competitors. However, independent of your association with the industry, PDA offers a community where all people are open to interact and share their passion to make a difference for patients. Receiving an award for such a community can only make you proud and even more committed to working even harder to support all the great PDA initiatives.
Receiving a PDA award is noticed by a lot of people in the industry, not only PDA members. It is recognition of a considerable contribution to the industry and opens doors both internally and externally, increasing your impact on the daily work in your company and also influencing the industry to benefit patients in the whole world. Everyone who contributes to the work of PDA uses a lot of their spare time on different PDA activities. This is not possible without the acceptance and active support from employers as well as our families. Because of this, having your contribution recognized is such a precious award.
I have also received the honor of being elected to the PDA Board of Directors. This is an extremely huge honor and I look forward to offering my humble contribution to PDA and the industry in this new role. My professional goals continue to be supporting the development and production of safe and effective medical products in a sustainable way to benefit as many patients around the world as possible. One of the areas I want to focus on even more in the coming years is to act as a mentor and source of knowledge for young entrepreneurs who have dedicated their lives to making innovative and new treatments for people with medical needs.
I am inspired working to help patients to get safe and efficient medicine, and I feel it is a huge commitment to deserve the trust patients have in us as an industry to do our utmost to ensure that the products we develop will help them get well and not make them more ill. As part of this commitment, I’m also passionate about that we do our best to minimize the environmental impact we have on the planet in the process of making medicine; it makes good sense to prevent the planet from sickness due to pollution caused by making medicine. On a more daily basis, I get inspired by working and interacting with people who have a passion for doing their jobs as well as possible. Since I have a curious and scientific mindset, I always want to learn more and be with people who inspire and teach me.
He believes; collaboration, knowledge sharing, and optimal use of all relevant technologies are the key factors in ensuring the availability of the best product for the patient.
Morten joined Fujifilm in 2020 where holds a role as Director, Global Alliance Management.
In 2001 he was one of the co-founders of CMC Biologics (now AGC Biologics) after he had been working 14 years at Novo Nordisk.
Furthermore, Morten has authored or contributed to several technical articles and guidelines. He is frequently invited to give scientific and technical presentations at international conferences. Additionally, he is active in the biopharmaceutical community as a member of scientific committees for various international conferences as well as a volunteer in international industry organizations, where the most important naturally is PDA, but also ISPE and BPOG.
- Service Appreciation Award
Your rating for this document has already been submitted
PDA President’s Award
This Award recognizes a PDA staff member, typically excluding Senior Staff members, whose exemplary performance has contributed to PDA’s success during the previous year.
Morten Munk
One common denominator for his approach is to have a holistic and broad perspective on all aspects and steps in the production of biopharmaceuticals.
I find it extremely awarding, to receive such a recognition from colleagues and peers in the industry. PDA is able to foster and support a unique platform for connecting people in the industry, which allows all of us to learn and share knowledge with colleagues from many areas of the industry, including regulators, suppliers and end-users, and that is even some who might be your competitors. However, independent of your association with the industry, PDA offers a community where all people are open to interact and share their passion to make a difference for patients. Receiving an award for such a community can only make you proud and even more committed to working even harder to support all the great PDA initiatives.
Receiving a PDA award is noticed by a lot of people in the industry, not only PDA members. It is recognition of a considerable contribution to the industry and opens doors both internally and externally, increasing your impact on the daily work in your company and also influencing the industry to benefit patients in the whole world. Everyone who contributes to the work of PDA uses a lot of their spare time on different PDA activities. This is not possible without the acceptance and active support from employers as well as our families. Because of this, having your contribution recognized is such a precious award.
I have also received the honor of being elected to the PDA Board of Directors. This is an extremely huge honor and I look forward to offering my humble contribution to PDA and the industry in this new role. My professional goals continue to be supporting the development and production of safe and effective medical products in a sustainable way to benefit as many patients around the world as possible. One of the areas I want to focus on even more in the coming years is to act as a mentor and source of knowledge for young entrepreneurs who have dedicated their lives to making innovative and new treatments for people with medical needs.
I am inspired working to help patients to get safe and efficient medicine, and I feel it is a huge commitment to deserve the trust patients have in us as an industry to do our utmost to ensure that the products we develop will help them get well and not make them more ill. As part of this commitment, I’m also passionate about that we do our best to minimize the environmental impact we have on the planet in the process of making medicine; it makes good sense to prevent the planet from sickness due to pollution caused by making medicine. On a more daily basis, I get inspired by working and interacting with people who have a passion for doing their jobs as well as possible. Since I have a curious and scientific mindset, I always want to learn more and be with people who inspire and teach me.
He believes; collaboration, knowledge sharing, and optimal use of all relevant technologies are the key factors in ensuring the availability of the best product for the patient.
Morten joined Fujifilm in 2020 where holds a role as Director, Global Alliance Management.
In 2001 he was one of the co-founders of CMC Biologics (now AGC Biologics) after he had been working 14 years at Novo Nordisk.
Furthermore, Morten has authored or contributed to several technical articles and guidelines. He is frequently invited to give scientific and technical presentations at international conferences. Additionally, he is active in the biopharmaceutical community as a member of scientific committees for various international conferences as well as a volunteer in international industry organizations, where the most important naturally is PDA, but also ISPE and BPOG.
- Service Appreciation Award
Your rating for this document has already been submitted

Rate this document Average rating:Your rating for this document has already been submitted